IL6 and Patent ductus arteriosus: Elevated CRP and/or IL-6 in clinical routine samples from cord blood were found in the high S100A group only, while the only significant difference regarding neonatal morbidities was a higher percentage in need of treatment for patent ductus arteriosus in the high S100A group.